BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25698715)

  • 1. Design and analysis of Bayesian adaptive crossover trials for evaluating contact lens safety and efficacy.
    Zhang Q; Toubouti Y; Carlin BP
    Stat Methods Med Res; 2017 Jun; 26(3):1216-1236. PubMed ID: 25698715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bayesian-bandit adaptive design for N-of-1 clinical trials.
    Shrestha S; Jain S
    Stat Med; 2021 Mar; 40(7):1825-1844. PubMed ID: 33462851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian model for joint analysis of multivariate repeated measures and time to event data in crossover trials.
    Liu F; Li Q
    Stat Methods Med Res; 2016 Oct; 25(5):2180-2192. PubMed ID: 24448442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian estimation of the proportion of treatment effect captured by a surrogate marker.
    Cowles MK
    Stat Med; 2002 Mar; 21(6):811-34. PubMed ID: 11870819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian analysis of time-series data under case-crossover designs: posterior equivalence and inference.
    Li S; Mukherjee B; Batterman S; Ghosh M
    Biometrics; 2013 Dec; 69(4):925-36. PubMed ID: 24289144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Equivalence Testing and Meta-Analysis in Two-Arm Trials with Binary Data.
    Kpekpena C; Muthukumarana S
    Comput Math Methods Med; 2018; 2018():8134132. PubMed ID: 30159005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P; Irony T; Liang S; Li X; Mukhi V; Ruan S; Xu Y; Yang X; Wang C
    J Biopharm Stat; 2011 Sep; 21(5):938-53. PubMed ID: 21830924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian randomized clinical trials: From fixed to adaptive design.
    Yin G; Lam CK; Shi H
    Contemp Clin Trials; 2017 Aug; 59():77-86. PubMed ID: 28455232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variance prior specification for a basket trial design using Bayesian hierarchical modeling.
    Cunanan KM; Iasonos A; Shen R; Gönen M
    Clin Trials; 2019 Apr; 16(2):142-153. PubMed ID: 30526008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simulation optimization for Bayesian multi-arm multi-stage clinical trial with binary endpoints.
    Yu Z; Ramakrishnan V; Meinzer C
    J Biopharm Stat; 2019; 29(2):306-317. PubMed ID: 30763151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical guide to Bayesian group sequential designs.
    Gsponer T; Gerber F; Bornkamp B; Ohlssen D; Vandemeulebroecke M; Schmidli H
    Pharm Stat; 2014; 13(1):71-80. PubMed ID: 24038922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BOB: Bayesian optimal design for biosimilar trials with co-primary endpoints.
    Chi X; Yu Z; Lin R
    Stat Med; 2022 Nov; 41(26):5319-5334. PubMed ID: 36127794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
    Doi M; Takahashi F; Kawasaki Y
    Stat Med; 2017 Dec; 36(30):4789-4803. PubMed ID: 28960376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extension of Bayesian predictive sample size selection designs for monitoring efficacy and safety.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2015 Sep; 34(22):3029-39. PubMed ID: 26038148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian hierarchical modeling of longitudinal glaucomatous visual fields using a two-stage approach.
    Bryan SR; Eilers PHC; Rosmalen JV; Rizopoulos D; Vermeer KA; Lemij HG; Lesaffre EMEH
    Stat Med; 2017 May; 36(11):1735-1753. PubMed ID: 28152571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.